Armistice Capital »

Western Alliance Bancorporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Western Alliance Bancorporation (WAL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Western Alliance Bancorporation

Tip: Access up to 7 years of quarterly data

All positions including Western Alliance Bancorporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Western Alliance Bancorporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.6M 100k 45.97
2023-06-30 $5.8M 160k 36.47

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Western Alliance Bancorporation

Vanguard Group
BlackRock
T. Rowe Price Associates
T. Rowe Price Investment Management
Dimensional Fund Advisors
Thrivent Financial for Lutherans
William Blair Investment Management
Davis Asset Management
Citadel Advisors
Wellington Management Company
Geode Capital Management
Balyasny Asset Management
Henderson Group
Vaughan Nelson Investment Management
Susquehanna International

View all funds holding Western Alliance Bancorporation